Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin R… (NCT07516509) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance
United States36 participantsStarted 2026-06
Plain-language summary
The purpose of this study is to find new signs or signals in muscle cells that can help us understand when the body isn't responding well to insulin (a condition called insulin resistance).
Who can participate
Age range30 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 30 to 65 years of age
✓. Stable weight (No Gain/Loss of \>10 lbs in 6 months)
. Currently pregnant (pregnancy test performed on day of DEXA scan in women of child-bearing potential); post-partum during the last 12 months; lactating during the last 12 months; planning to become pregnant during the participation period